Novel Peptide Progresses to Phase 2 for the Treatment of Severe Burns STONY BROOK, NY, February 5, 2025 (EINPresswire.com) – NeoMatrix...

NeoMatrix Therapeutics (NMT) Peptide Discovery Advances Treatment of Burn Injury. Novel Peptide Shows Promise for the Treatment of Severe...

- Novel Peptide to Advance to Phase 2 for the Treatment of Severe Burns -

- Potential First-in-Class Treatment for Serious Burn Injuries Targets PDGF -